Longitudinal Clinical Course, Treatment Outcomes, and Relapse Patterns in Alopecia Areata: A Prospective Cohort Study

November 2025 in “ Frontiers in Medicine ”

Wenjie Yan, Yue Wang, Mengjiao Wang, Zhao Yu-mei, Xi Huang

alopecia areata baseline severity disease activity relapse history standardized severity scores patient-reported outcomes imaging biomarkers AA

TLDR Baseline severity and relapse history affect alopecia areata treatment and recurrence.

This study on alopecia areata (AA) highlights that baseline severity, disease activity, and relapse history significantly influence treatment response and recurrence. The research suggests that using standardized severity scores, patient-reported outcomes, and imaging biomarkers can enhance risk stratification, personalize patient care, and improve the real-world assessment of existing therapies.

View this study on public-pages-files-2025.frontiersin.org →

Discuss this study in the Community →

Research cited in this study

25 / 25 results

research Global Burden of Alopecia Areata from 1990 to 2019 and Emerging Treatment Trends Analyzed Through GBD 2019 and Bibliometric Data

5 citations , July 2025 in “Scientific Reports”

Alopecia areata affects women and young adults most, with low SDI regions seeing the highest increase, and new treatments like JAK inhibitors are being explored.

research Immune-Mediated Disorders in Patients With Alopecia Areata: Systematic Review and Meta-Analysis

7 citations , July 2025 in “International Journal of Dermatology”

This meta-analysis of 18 studies involving 462,945 alopecia areata (AA) patients and 11,488,192 healthy controls found that AA is significantly associated with an increased risk of various immune-mediated comorbidities. Notably, the odds ratios (ORs) for comorbid conditions such as vitiligo (OR 6.61), systemic lupus erythematosus (OR 3.28), and autoimmune thyroiditis (OR 1.57) were elevated. The prevalence of these comorbidities varied, with atopic disorders being the most common at 38.65%. These results highlight the importance of comprehensive screening and interdisciplinary management for patients with AA due to their heightened risk of other immune-mediated diseases.

research Serum-Based Assessment of Alopecia Areata Response to Treatment Using ATR-FTIR Spectroscopy

2 citations , May 2025 in “Diagnostics”

ATR-FTIR spectroscopy could help monitor alopecia areata treatment response non-invasively.

research Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023

4 citations , May 2025 in “Dermatology and Therapy”

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

research Unveiling the Immune and Vitamin Profiles of Blood: Potential Biomarkers for Alopecia Areata

May 2025 in “PeerJ”

Certain immune markers and vitamin levels could help diagnose alopecia areata.

research Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment

3 citations , April 2025 in “American Journal of Clinical Dermatology”

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

research Evaluation of SALT Score Severity in Correlation With Trichoscopic Findings in Alopecia Areata: A Study of 303 Patients

7 citations , March 2025 in “Archives of Dermatological Research”

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

research Switching JAK Inhibitors: Evaluating Baricitinib’s Effectiveness in Alopecia Areata After Tofacitinib Failure

2 citations , February 2025 in “Archives of Dermatological Research”

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

research Dual Improvement of Alopecia Areata and Immune Thrombocytopenia With Baricitinib: A Case Report

January 2025 in “Skin Health and Disease”

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

research Identifying Effective Immune Biomarkers in Alopecia Areata Diagnosis Based on Machine Learning Methods

3 citations , January 2025 in “BMC Medical Informatics and Decision Making”

Machine learning can help find new ways to treat alopecia areata.

research Comparative Efficacy and Safety of Systemic Steroids, Oral JAK Inhibitors, and Contact Immunotherapy in the Treatment of Severe Alopecia Areata: A Systematic Review and Network Meta-Analysis

3 citations , July 2024 in “Archives of Dermatological Research”

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

research A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System

June 2024 in “Military medicine”

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Construction of Regulatory Network for Alopecia Areata Progression and Identification of Immune Monitoring Genes Based on Multiple Machine-Learning Algorithms

research Construction of Regulatory Network for Alopecia Areata Progression and Identification of Immune Monitoring Genes Based on Multiple Machine-Learning Algorithms

3 citations , May 2023 in “Precision clinical medicine”

Researchers found four genes that could help diagnose severe alopecia areata early.

research Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population

75 citations , March 2023 in “JAMA Dermatology”

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

research Prevalence of Alopecia Areata in Japan: Estimates from a Nationally Representative Sample

18 citations , November 2022 in “The Journal of Dermatology”

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.

research Prevalence, Comorbidities, and Treatment Patterns of Japanese Patients with Alopecia Areata: A Descriptive Study Using Japan Medical Data Center Claims Database

35 citations , November 2022 in “The Journal of Dermatology”

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

research Alopecia Areata as an Immune-Related Adverse Event Associated with Response to Immune Checkpoint Inhibitors

3 citations , July 2022 in “European Journal of Dermatology”

research Prevalence and Risk Factors Associated with the Occurrence of Autoimmune Diseases in Patients with Alopecia Areata

14 citations , September 2021 in “Journal of Inflammation Research”

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Tofacitinib for the Treatment of Three Immune-Mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata

research Tofacitinib for the Treatment of Three Immune-Mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata

5 citations , January 2021 in “Inflammatory Bowel Diseases”

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

research Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 NKG2D Lymphocytes in Alopecia Areata Patients

15 citations , December 2018 in “International journal of environmental research and public health/International journal of environmental research and public health”

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

research High-Throughput T Cell Receptor Sequencing Identifies Clonally Expanded CD8+ T Cell Populations in Alopecia Areata

46 citations , October 2018 in “JCI insight”

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

research Quantifying Alopecia Areata via Texture Analysis to Automate the SALT Score Computation

20 citations , December 2017 in “Journal of Investigative Dermatology Symposium Proceedings”

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

research SOCS3 Treatment Prevents the Development of Alopecia Areata by Inhibiting CD8+ T Cell-Mediated Autoimmune Destruction

16 citations , March 2017 in “Oncotarget”

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

research CD8-Positive Mycosis Fungoides Clinically Masquerading as Alopecia Areata

8 citations , August 2016 in “Journal of Cutaneous Pathology”

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

research Human Leukocyte Antigen Class II Alleles Are Associated with Risk of Alopecia Areata

36 citations , July 2007 in “Journal of Investigative Dermatology”

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Similar Research

5 / 1000+ results

research Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia-Pacific Modified Delphi Expert Panel Recommendations

February 2026 in “International Journal of Dermatology”

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases